Bacillus clausii
Bacillus clausii is a pharmaceutical drug with 8 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effect of Use of Probiotics on Systemic Infection in Critically Ill Patients: a Double Blind, Randomized, Placebo-controlled Trial
Comparison of Effectiveness of Zinc Supplementation With ORS and Bacillus Clausii Versus Zinc With ORS and Saccharomyces Boulardii in Acute Watery Diarrhea in Paediatric Patients
Probiotics, Respiratory and Intestinal Microbiome and Respiratory Tract Infections in Children
Impact of Bacillus Clausii Administration on Irritable Bowel Syndrome Patients
Evaluation Of Bacillus Clausii In Treatment Of Acute Diarrhea In Latin American Children
Clinical Trials (8)
Effect of Use of Probiotics on Systemic Infection in Critically Ill Patients: a Double Blind, Randomized, Placebo-controlled Trial
Comparison of Effectiveness of Zinc Supplementation With ORS and Bacillus Clausii Versus Zinc With ORS and Saccharomyces Boulardii in Acute Watery Diarrhea in Paediatric Patients
Probiotics, Respiratory and Intestinal Microbiome and Respiratory Tract Infections in Children
Impact of Bacillus Clausii Administration on Irritable Bowel Syndrome Patients
Evaluation Of Bacillus Clausii In Treatment Of Acute Diarrhea In Latin American Children
EFESO - EFficacy Enterogermina Small Intestinal Bacterial Overgrowth
ENterogermina® (Bacillus Clausii) In the manaGeMent of diarrheA in Children
DIAMANTE - Diseases Infectious Analysis Microflora Antibiotic Effect
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8